Dabigatran etexilate retards the initiation and progression of atherosclerotic lesions and inhibits the expression of oncostatin M in apolipoprotein E-deficient mice - Preusch, M R; Ieronimakis, N; Wijelath, E S (Drug Des Devel Ther, 2015)